Binmac Capsules 61mg, manufactured by Pfizer, contain Tafamidis. With a YJ code of 2190043M1025 and a standard of 61mg per capsule, this medication is primarily used to treat transthyretin amyloid cardiomyopathy (ATTR-CM) to reduce cardiovascular mortality and cardiovascular-related hospitalizations.
Binmac Capsules 61mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →